复星医药(02196)获控股股东复星高科技质押2000万股及解除质押8575万股A股

Core Viewpoint - Fosun Pharma (02196) announced that its controlling shareholder, Shanghai Fosun High Technology (Group) Co., Ltd., has pledged and released part of its A-share holdings in the company, indicating ongoing financial maneuvers within the company [1] Group 1 - The controlling shareholder pledged 20 million shares of Fosun Pharma [1] - The controlling shareholder released 85.75 million shares from pledge [1]